東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Metabolic dysfunction-associated ste...

Méndez-Sánchez, Nahum.

FindBook

Google Book

Amazon

博客來

Metabolic dysfunction-associated steatotic liver disease = prevalence, research insights and the future directions /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Metabolic dysfunction-associated steatotic liver disease/ edited by Nahum Méndez-Sánchez, Xingshun Qi.
其他題名:	prevalence, research insights and the future directions /
其他作者:	Méndez-Sánchez, Nahum.
出版者:	Singapore :Springer Nature Singapore : : 2024.,
面頁冊數:	viii, 170 p. :ill. (chiefly color), digital ;24 cm.
內容註:	Chapter 1 Introduction of MAFLD/MASLD. -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC. -- Chapter 3 Decoding MAFLD's pathophysiology. -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage. -- Chapter 5 Diagnostic Advances in MAFLD/MASLD. -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes. -- Chapter 7 MAFLD as a multisystemic disease. -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship. -- Chapter 9 Current Standards in Therapeutic Management. -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS. -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management. -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS. -- Chapter 13 Looking ahead. -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.
Contained By:	Springer Nature eBook
標題:	Fatty liver - Pathophysiology. -
電子資源:	https://doi.org/10.1007/978-981-97-9519-2
ISBN:	9789819795192

Metabolic dysfunction-associated steatotic liver disease = prevalence, research insights and the future directions /
Metabolic dysfunction-associated steatotic liver diseaseprevalence, research insights and the future directions /[electronic resource] :edited by Nahum Méndez-Sánchez, Xingshun Qi. - Singapore :Springer Nature Singapore :2024. - viii, 170 p. :ill. (chiefly color), digital ;24 cm.

Chapter 1 Introduction of MAFLD/MASLD. -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC. -- Chapter 3 Decoding MAFLD's pathophysiology. -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage. -- Chapter 5 Diagnostic Advances in MAFLD/MASLD. -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes. -- Chapter 7 MAFLD as a multisystemic disease. -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship. -- Chapter 9 Current Standards in Therapeutic Management. -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS. -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management. -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS. -- Chapter 13 Looking ahead. -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.

This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.

ISBN: 9789819795192

Standard No.: 10.1007/978-981-97-9519-2doiSubjects--Topical Terms:

3754877
Fatty liver
--Pathophysiology.

LC Class. No.: RC848.F3

Dewey Class. No.: 616.362

Metabolic dysfunction-associated steatotic liver disease = prevalence, research insights and the future directions /
LDR:02612nmm a2200325 a 4500 001 2389277
003 DE-He213
005 20241231115242.0
006 m d
007 cr nn 008maaau
008 250916s2024 si s 0 eng d
020 $a 9789819795192 $q (electronic bk.)
020 $a 9789819795185 $q (paper)
024 7 $a 10.1007/978-981-97-9519-2 $2 doi
035 $a 978-981-97-9519-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.F3
072 7 $a MNG $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MNG $2 thema
082 0 4 $a 616.362 $2 23
090 $a RC848.F3 $b M587 2024
245 0 0 $a Metabolic dysfunction-associated steatotic liver disease $h [electronic resource] : $b prevalence, research insights and the future directions / $c edited by Nahum Méndez-Sánchez, Xingshun Qi.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a viii, 170 p. : $b ill. (chiefly color), digital ; $c 24 cm.
505 0 $a Chapter 1 Introduction of MAFLD/MASLD. -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC. -- Chapter 3 Decoding MAFLD's pathophysiology. -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage. -- Chapter 5 Diagnostic Advances in MAFLD/MASLD. -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes. -- Chapter 7 MAFLD as a multisystemic disease. -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship. -- Chapter 9 Current Standards in Therapeutic Management. -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS. -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management. -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS. -- Chapter 13 Looking ahead. -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.
520 $a This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.
650 0 $a Fatty liver $x Pathophysiology. $3 3754877
650 0 $a Fatty liver $x Treatment. $3 3754878
650 1 4 $a Gastroenterology. $3 828956
700 1 $a Méndez-Sánchez, Nahum. $3 3754876
700 1 $a Qi, Xingshun. $3 3445583
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-9519-2
950 $a Medicine (SpringerNature-11650)